HOME › Research Insight › Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland) Dominate the global High-Throughput Screening Market
Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland) Dominate the global High-Throughput Screening Market
The global high-throughput screening market is highly fragmented in the nature with the presence of a number of small and medium-sized players operating at local and regional levels. Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland) are some of the leaders in the global high-throughput screening market. These players have a strong presence in major as well as emerging markets. Other players in this market include Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).
While product innovation remains at the center of the strategic growth initiatives pursued by a majority of the key players in the global high-throughput screening market, players are also focusing on increasing their presence in the high-growth markets through the mode of agreements, partnerships, collaborations, expansions and acquisitions.
Agilent Technologies’ leading position in the high-throughput screening market is mainly attributed to its broad HTS product portfolio. This company is a global provider of solutions in the diagnostics, life sciences, and applied chemical markets and operates in the Americas, Europe, the Middle East, Asia-Pacific, and Africa. During 2013 to 2016, the company focused on both organic as well as inorganic growth strategy to strengthen its market position in HTS market. For instance, in January 2016, announced the extension of its agreement with PerkinElmer, Inc. (U.S.) of supplying chips for its 2100 Bioanalyzer system. Similarly, in October 2015, the company launched 4200 TapeStation for high-throughput and quality screening.
Danaher Corporation is a global science and technology company that operates through five business segments—Test and Measurement, Environmental, Industrial Technologies, Dental, and Life Sciences & Diagnostics.
In 2015, the company has invested USD 1,239.1 million (around 6% of the total revenue) in R&D; this reflects company’s high focus on innovation and development of the new products and technology. For instance, in April 2015, Molecular Devices (a subsidiary of Danaher Corporation) launched SpectraMax i3x Multi-Mode Microplate Reader for in-depth cellular pathway analysis.
Some other leading players in the global high-throughput screening market include Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland). These companies have well-established sales and distribution networks. They also make significant investments in R&D activities to add innovative technologies and products to their portfolio. With a strong portfolio of HTS products and ceaseless efforts to develop innovative products, these companies are likely to maintain their strong position in the market in the coming years as well.
High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India